Reimbursement status of authorised biosimilars in MS and EFTA countries (Platform on access to medicines in Europe - Market access for biosimilars)
Dokumento data: Wed Apr 17 00:00:00 CEST 2013
- Sukūrė ENTR.R.4
- Paskelbimo data: Wed Nov 19 12:56:34 CET 2014
Nuorodos:
Copy / paste the snippet below to render the highlighted section on your page.